Groundbreaking heart valve device developed in Tulsa gives hope to those ineligible for traditional heart surgeries—discover how it’s transforming medical treatments. A team at the Oklahoma Heart ...
One-year outcomes in the ENCIRCLE trial’s main cohort (299 patients unsuitable for other treatment options) achieved low rates for death and low heart failure hospitalization for patients treated with ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
A team at the Oklahoma Heart Institute is helping patients across the globe with a groundbreaking device that could change how doctors treat mitral valve disease. Developed by Edwards Lifesciences and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results